Fadhli Hasim

Software Developer at Hematogenix

Fadhli Hasim is a proficient software developer with extensive experience in application development and system support, currently employed at Hematogenix since November 2019. Prior roles include Senior System Developer at AEM Energy Solutions Sdn Bhd and Software Senior Engineer at Dell, where Fadhli Hasim contributed to the software development life cycle, application analysis, and provided technical support. Previous experience also encompasses leadership in a programming team at Astro and development of filtering software at e-Safe Systems Sdn Bhd. Fadhli Hasim holds a Bachelor's Degree in Information Technology from Kuala Lumpur Metropolitan University College and a Diploma in Computer Science from Cosmopoint Institute of Information Technology.

Location

Cyberjaya, Malaysia

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Hematogenix

1 followers

Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant